| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |